# Your page scores 60 out of 100 for sameness against the 3 competitors you named.

Most of what your page says, Bluesight says too — the overlap is heaviest in what you say you do and who it's for.

- **Your page:** https://intelliguardhealth.com/
- **Compared against:** Bluesight (bluesight.com), Terso Solutions (tersosolutions.com), Marble (marble-ai.com)
- **Sameness Index:** 60 — Mostly the same
- **Ownable share:** 27% (of 46% distinctive)
- **Report:** https://grader.wynter.com/c/intelliguardhealth-com-3xfbfsg

**How you compare · vs 366 SaaS sites** — 4 points more same than the average SaaS site. The average SaaS site scores 56; you scored 60. You are less same than 139 of the 366 SaaS sites. The best-differentiated site in the set is at 6.
_A single check can move several points between runs; the benchmark averages up to eight sites per category._

> With 3 competitors, commonness can only take 4 distinct values. The figures are honest at that resolution and no finer.

## 1. Sameness Index

| Category | Weight | Score | What it means |
| --- | --- | --- | --- |
| Messaging | 30% | 69 | The most expensive kind of sameness. A buyer cannot tell what job you do that the others do not. |
| Claims | 30% | 67 | Every shared claim is a line already read on another tab. Cut the ones nobody owns and spend the space on something they cannot. |
| Features | 15% | 56 | Expected in a mature category, and the least alarming of the six. Feature parity is normal; leading with it is the mistake. |
| Proof | 10% | 27 | Same kinds of proof as everyone means the proof stops working as proof. It is scored on the kind of evidence, not on which customers are named. |
| Structure | 10% | 51 | The generic SaaS template — hero, logos, three-feature grid, testimonial, CTA. Familiar is not the same as memorable. |
| Visual | 5% | 56 | Weighted lowest on purpose: buyers rarely decide on this. Worth knowing, rarely worth fixing first. |

**Mostly the same** — Most of your claims are also theirs. Only the details differ.

## 2. Closest competitors

| Competitor | Same | Band |
| --- | --- | --- |
| Bluesight | 79 | Interchangeable |
| Marble | 64 | Mostly the same |
| Terso Solutions | 34 | Mostly your own |

_Measured from your side: how much of what YOU say each competitor also says, weighted by where you put it._

## 3. Ownable share

**The share of your own page's claim space that is yours to keep.** This is not the inverse of the Sameness Index — it is measured on your claims alone, so the two do not add up to 100 and are not meant to.

27% of your page is unique, relevant and defensible — a strong share, and the thing to protect in any rewrite.

- **Distinctive message share:** 46% — prominent space spent on claims no competitor makes.
- **Ownable share:** 27% — the part of that which is also relevant to how buyers choose and hard to copy.

## 4. Where you sound like everyone else

Most of your set makes each of these and you are spending prominent space on them, ranked by how much. **These are not necessarily lines to delete** — some of what a page has to say is unavoidably shared, and claims about what kind of product you are were left out of this list for exactly that reason. The question each one raises is whether it has earned its space.

- **real-time item-level inventory visibility** (Hero, 100% of the set) — also on Bluesight, Terso Solutions, Marble
  - _"Know Exactly Where Every Critical, High-Value Medication is in Real Time"_
- **purpose-built for hospital pharmacy and healthcare** (Hero, 67% of the set) — also on Bluesight, Terso Solutions
  - _"For Health Systems"_
- **named customers and install base as proof** (Section, 100% of the set) — also on Bluesight, Terso Solutions, Marble
  - _"600+ Hospitals Served"_
- **real-time item-level inventory visibility** (Section, 100% of the set) — also on Bluesight, Terso Solutions, Marble
  - _"Enterprise-wide control"_
- **named customers and install base as proof** (Section, 100% of the set) — also on Bluesight, Terso Solutions, Marble
  - _"50M+ Medications Tracked"_
  - Said your way: nobody else makes this exact claim, but everyone occupies the territory.
- **AI delivers predictive, actionable guidance** (Section, 67% of the set) — also on Bluesight, Marble
  - _"Mira Intelligence+ delivers predictive insights and translates them into daily, role-based actions"_
- **reduces waste, cost and improves financial control** (Section, 67% of the set) — also on Bluesight, Marble
  - _"Better financial control"_
- **saves staff time on manual work** (Section, 67% of the set) — also on Bluesight, Marble
  - _"Less manual work, more clinical focus"_

## 5. Buried gold

Unique, relevant, and sitting in body copy. The cheapest wins here — you already have the differentiation and the page hides it.

- **Case- and clinician-level accountability per transaction** (Body, 0% of the set)
  - _"Case-level accountability across anesthesiology, surgery, and nursing"_
- **Utilization data supports charge capture and 340B** (Body, 0% of the set)
  - _"Precise utilization data for charge capture and 340B reconciliation"_
- **Automated temperature, expiry and recall alerts** (Body, 0% of the set)
  - _"Temperature excursion, expiry, and recall alerts pushed to you"_

## 6. Claim inventory

| Claim | Type | Placement | Common | Sayability | Relevant | Ownership |
| --- | --- | --- | --- | --- | --- | --- |
| Real-time item-level visibility into every medication | outcome | Hero | 33% | some | yes | Contested |
| Built for health systems / hospital pharmacy | segment | Hero | 67% | anyone | yes | Commodity |
| Only/first connected RFID ecosystem for medications | category | Hero | 0% | some | yes | Unique and owned |
| Installed at hundreds/thousands of hospitals | proof | Section | 67% | some | yes | Commodity |
| Trusted by leading healthcare organizations | proof | Section | 67% | anyone | yes | Commodity |
| Enterprise-wide control of high-value inventory | outcome | Section | 33% | anyone | yes | Contested |
| Volume of medications tracked to date | proof | Section | 0% | some | no | Unique and owned |
| AI turns data into predictive, role-based actions | capability | Section | 67% | anyone | yes | Commodity |
| Better financial control / lower costs | outcome | Section | 67% | anyone | yes | Commodity |
| Less manual work frees staff time | outcome | Section | 67% | anyone | yes | Commodity |
| Open standards integration without rip-and-replace | capability | Section | 67% | some | yes | Commodity |
| Fast secure medication access without workflow disruption | quality | Section | 33% | anyone | yes | Contested |
| Improves compliance and audit readiness | outcome | Section | 33% | anyone | yes | Contested |
| Accurate data captured at the source | quality | Section | 0% | anyone | yes | Unique for now |
| Modular expansion across the full workflow | capability | Section | 0% | some | yes | Unique and owned |
| Quantified accuracy rate of ~99% | proof | Section | 0% | some | yes | Unique and owned |
| Reduces drug waste and expiration loss | outcome | Section | 0% | anyone | yes | Unique for now |
| Single platform with one integration | capability | Section | 0% | some | yes | Unique and owned |
| Self-serve ROI calculator in 60 seconds | outcome | Section | 0% | anyone | no | Unique for now |
| Tags and verifies inventory at receipt or prep | capability | Section | 0% | some | yes | Unique and owned |
| Unified view integrating RFID, EHR, ADC and other systems | capability | Body | 100% | some | yes | Commodity |
| Detects or deters drug diversion | outcome | Body | 33% | some | yes | Contested |
| Every transaction documented automatically | capability | Body | 33% | some | yes | Contested |
| Case- and clinician-level accountability per transaction | capability | Body | 0% | some | yes | Unique and owned |
| Models multi-year savings including 340B revenue | capability | Body | 0% | some | no | Unique and owned |
| Utilization data supports charge capture and 340B | capability | Body | 0% | some | yes | Unique and owned |
| Automated temperature, expiry and recall alerts | capability | Body | 0% | some | yes | Unique and owned |
| Holds RFID patents | proof | Body | 0% | structural | no | Unique and owned |

## What we compared

- **Intelliguard** (your page) — https://intelliguardhealth.com/
- **Bluesight** — https://bluesight.com/
- **Terso Solutions** — https://www.tersosolutions.com/
- **Marble** — https://www.marble-ai.com/

## What this does and does not tell you

An AI read each page and wrote down the claims it makes, then grouped the claims that say the same thing. **No score in this report was written by a model** — every number is computed from those groupings in our own code, with the weights shown above.

## The only way to know if it matters

This report can tell you where your messaging overlaps. It cannot tell you whether a buyer would care, or which of your reasons to buy actually land. Put the page in front of real B2B buyers in your target market and ask them.

[Test it with real buyers](https://wynter.com)